EP3484853 - Bibliographic data

PROCÉDÉ DE PRODUCTION D'UNE FORME POLYMORPHE DE 3- [5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-MÉTHYLBENZAMIDE

Last update 20/05/2025
Legal status Brevet délivré
Origin Euro-PCT

(73) Holder

Mereo BioPharma 1 Limited

1 Cavendish Place
London, Greater London W1G 0QF
Royaume-Uni
(72) Inventors

Osama SULEIMAN

Johnson Matthey Plc. Fine Chemicals Division (Pharmorphix) 250 Cambridge Science Park Milton Road
Cambridge Cambridgeshire CB4 0WE
Royaume-Uni

Lucia Romero PEREZ

Johnson Matthey Plc. Johnson Matthey Chemical Product Orchard Road
Royston Hertfordshire SG8 5HE
Royaume-Uni

Cornelius Stephan HARLACHER

Zihlackerstrasse 60
4153 Reinach
Suisse

Stewart JONES

Mereo Biopharma Group plc 4th Floor 1 Cavendish Place
London Greater London W1G 0QF
Royaume-Uni
(74) Agent

Mail recipient

Gill Jennings & Every LLP

The Broadgate Tower 20 Primrose Street
London EC2A 2ES
Royaume-Uni

(21) Request number EP17742277.1
(22) Request date 13/07/2017

(11) Publication number EP3484853
Publication date 21/04/2021

(54) Title of the invention PROCÉDÉ DE PRODUCTION D'UNE FORME POLYMORPHE DE 3- [5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-MÉTHYLBENZAMIDE
(51) International classification C07D 231/38A61K 31/415A61P 29/00
International classification (before reform) None

Claimed priority

(31) Number: 201612238
(32) Date: 14/07/2016
(33) Country: GB

Initial application None
Divisional application None

Expected annuity Annuity: 9 - Amount: 175 € - Due date 31/07/2025
Last annuity Annuity: 8 - Payment date 27/06/2024

Publication None
History

Publication de la délivrance du brevet européen - Legal date 21/04/2021